To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, tolerability, pharmacokinetics and
pharmacodynamics of AZD8329 following multiple ascending dose administrations in in
overweight to obese but otherwise healthy male subjects.